Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
Angelo L. Grauel, Beverly Nguyen, David A. Ruddy, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 150

Showing 26-50 of 150 citing articles:

Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
Agathe Peltier, Romain-David Seban, Irène Buvat, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 262-272
Open Access | Times Cited: 64
TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective
Briana G. Nixon, Shengyu Gao, Xinxin Wang, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 346-362
Open Access | Times Cited: 59
Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion
Elizabeth R. Murray, Shinelle Menezes, Jack C. Henry, et al.
Cell Reports (2022) Vol. 38, Iss. 4, pp. 110227-110227
Open Access | Times Cited: 57
Facts and Hopes in Immunotherapy of Pancreatic Cancer
Bruno Bockorny, Joseph E. Grossman, Manuel Hidalgo
Clinical Cancer Research (2022) Vol. 28, Iss. 21, pp. 4606-4617
Closed Access | Times Cited: 57
TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
Shinelle Menezes, Mohamed Hazem Okail, Siti Munira Abd Jalil, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 4, pp. 526-544
Open Access | Times Cited: 52
Spatial transcriptomics technology in cancer research
Qichao Yu, Miaomiao Jiang, Liang Wu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 44
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy
Qiang Li, Megan T. Hoffman, Lestat R. Ali, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 874-890.e10
Open Access | Times Cited: 37
Bifidobacterium adolescentis orchestrates CD143+ cancer‐associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling‐regulated GAS1
Shujie Chen, Lina Fan, Yifeng Lin, et al.
Cancer Communications (2023) Vol. 43, Iss. 9, pp. 1027-1047
Open Access | Times Cited: 29
Fibroblasts as Turned Agents in Cancer Progression
Robert Wieder
Cancers (2023) Vol. 15, Iss. 7, pp. 2014-2014
Open Access | Times Cited: 28
The impact of hypoxia on tumor-mediated bypassing anti-PD-(L)1 therapy
Keywan Mortezaee, Jamal Majidpoor, Ebrahim Kharazinejad
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114646-114646
Open Access | Times Cited: 27
INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer
Ye Hu, María Sol Recouvreux, Marcela Haro, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 15
TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts
Maria Perez-Penco, Lucía Lara de la Torre, Inés Lecoq, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008405-e008405
Open Access | Times Cited: 12
YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer
Hongtao Song, Tong Lü, Donghui Han, et al.
Cancer Research (2024) Vol. 84, Iss. 22, pp. 3728-3742
Open Access | Times Cited: 11
The Role of Transglutaminase 2 in Cancer: An Update
Elisabetta Zaltron, Federica Vianello, Alessia Ruzza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2797-2797
Open Access | Times Cited: 10
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
IFNγ and TNFα drive an inflammatory secretion profile in cancer‐associated fibroblasts from human non‐small cell lung cancer
Lilian Koppensteiner, Layla Mathieson, LYNNE NEILSON, et al.
FEBS Letters (2025)
Open Access | Times Cited: 1
Interrogation of the Tumor Microenvironment by Nanoparticles
Prasanta Panja, Upender Manne, Vibhudutta Awasthy, et al.
Cancer Letters (2025), pp. 217454-217454
Closed Access | Times Cited: 1
Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence
Jing‐Xuan Xu, Yuangang Su, Yuanyuan Chen, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Cancer-Associated Fibroblasts in Oral Cancer: A Current Perspective on Function and Potential for Therapeutic Targeting
Kamila Bienkowska, Christopher J. Hanley, Gareth J. Thomas
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 50
Define and visualize pathological architectures of human tissues from spatially resolved transcriptomics using deep learning
Yuzhou Chang, Fei He, Juexin Wang, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 4600-4617
Open Access | Times Cited: 37
Spatial Transcriptomics for Tumor Heterogeneity Analysis
Qiongyu Li, Xinya Zhang, Rongqin Ke
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 33
Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions
Benjamin Jenkins, Josephine F. Buckingham, Christopher J. Hanley, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108231-108231
Open Access | Times Cited: 31

Scroll to top